May04Fri

Member News from Almac Group

Almac Group Participates in National Take Our Daughters and Sons to Work Day

A STEM-focused event serving over 150 children at four US facilities

Souderton, U.S., May 4, 2018– Almac Group, the global contract pharmaceutical development and manufacturing organization with North American headquarters in Souderton, PA, participated in the nationally organized Take Our Daughters and Sons to Work Day, coordinating a full event schedule for over one-hundred and fifty children of Almac employees.
Organized into groups according to age, the projects covered the company’s unique service areas, including science demonstrations, clinical packaging relays, tours of supply chain warehouses, and individualized career development. Participants at Almac’s Durham, North Carolina facility had the opportunity to dissect a strawberry’s DNA, guided by diagnostic subject-matter-experts. Each group also contributed to organizing care packages to help our military heroes, aiding the Military Working Dog Team Support Association.

Read More

May03Thu

Member News from Aramark

Aramark Named a Top 50 Company for Diversity by DiversityInc

Aramark (NYSE: ARMK), a global leader in food, facilities management and uniforms, was once again named to DiversityInc’s Top 50 Companies for diversity list.

“We are proud to be recognized by DiversityInc as a Top 50 company and share this honor with our 270,000 associates around the world,” said Lynn McKee, Executive Vice President of Human Resources for Aramark. “The strength and success of our company is fueled by our diverse team members who proudly represent many different backgrounds, perspectives, talents, beliefs and values.”

Read More

May03Thu

Member News: ICON announces financial results for the first quarter 2018

ICON Reports First Quarter 2018 Results

Highlights from the quarter include:

– ICON Helps Establish New Industry Standards Group to Improve Clinical Trial Collaboration and Execution
– ICON opens a new office in Boston
– Excluding the impact of ASC 606, net business wins in the quarter were $590 million; a book to bill of 1.28.
– Excluding the impact of ASC 606, closing backlog of $5,053 million, an increase of 17.2% year on year.
– Quarter 1 reported revenue of $620.1 million. Excluding the impact of ASC 606, quarter 1 revenue was $462.6 million, representing a 7.1% increase year on year.
– Reported income from operations was $91.7 million, or 14.8% of revenue. Excluding the impact of ASC 606 income from operations was $92.8 million or 20.1% of revenue.
– Reported earnings per share of $1.42. Excluding the impact of ASC 606, earnings per share of $1.44, an 11.6% increase year on year.
– Earnings guidance increased by $0.02 to reflect quarter 1 share repurchases to $5.91 – $6.11. Revenue guidance reconfirmed in the range of $2,520 – $2,640 million.

Read More

May01Tue

Member News from Almac Group

Almac Group Appoints David Taylor as Head of Manufacturing Operations

N.I., 01 May 2018 – David Taylor joined the Almac Group in November 2017 as Head of Manufacturing, Almac Sciences.  He is tasked with the overall accountability for small molecule API and peptide manufacturing in Craigavon, and delivering on Almac’ Sciences’ supply chain operations at the Northern Ireland site.  David has worked in the pharmaceutical and fine chemical industries for over twenty-two years, and brings with him a strong background in both the technical and manufacturing disciplines, allowing him to lead multidisciplinary teams to deliver streamlined operational outcomes. In an industry with significant emphasis on safety, quality and regulatory compliance, David has the skill set needed to anticipate and successfully communicate planning and procurement changes to customers, clients and third-parties abroad.

Read More